Overview

Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents

Status:
Completed

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

This study is to verify the efficacy of fluvoxamine maleate given for 8 weeks in the treatment of children and adolescents with depression or depressive state

Phase:

Phase 4

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Fluvoxamine
Maleic acid